Miraculins

Developing and Commercializing Diagnostic Tests for Unmet Clinical Needs

Saving Lives Through Early Disease Diagnosis

Miraculins is an emerging biotechnology company committed to extending life, reducing suffering and lowering healthcare costs. 

Through our leadership in the development and commercialization of diagnostic tests, we strive to improve the overall diagnosis and treatment of patients by enhancing the information available to physicians.

The Miraculins Advantage

Products & Programs

Miraculins is dedicated to the development and commercialization of diagnostic tests for diseases and conditions that are lacking highly sensitive and specific tests.

Research & Technology

Miraculins is focused on acquiring diagnostic technologies that have gone through early research and discovery stages at the university or research institution level, but are not yet ready for commercialization.  The Company adds value by developing the technology into clinical grade quality and by driving it through regulatory approval and ultimately to sales.

Investor Relations

MOM listed on TSX Venture Exchange

Go to Stock Quote & Chart

JANUARY 13, 2010: Miraculins Selected as one of Emerging Growth Stocks January Picks

Link to Reprint Here

Sign Up for E-Mail Updates From Miraculins



Sign Up Now Privacy Policy